对于严重的COVID-19肺炎,低剂量肺部放射治疗是否是一种治疗替代方案?
Fatima Safini1,2, Bouchra Amaoui1,2, Kenza Oqbani2
1Department of Radiation Therapy, Souss-Massa University Hospital, Agadir, MAR.
Cureus
|August 21, 2024
概括
低剂量放射治疗 (LD-RT) 为严重的肺炎提供了替代治疗方法,包括由SARS-CoV-2引起的肺炎. 本综述强调了其抗炎作用和对患者的临床益处.
科学领域:
- 免疫学 免疫学 免疫学
- 辐射疗法 辐射疗法
- 传染性疾病 传染性疾病
背景情况:
- 低剂量放射治疗 (LD-RT) 在历史上是用于肺炎,由于免疫调节作用.
- 抗生素和对致癌风险的担忧导致LD-RT使用量下降.
- 由于SARS-CoV-2大流行,人们对重症,耐治疗性肺炎的LD-RT重新产生了兴趣.
研究的目的:
- 审查LD-RT作为重症肺炎治疗选择的疗效.
- 评估LD-RT的抗炎和临床益处.
- 整合已发表的肺炎LD-RT临床试验的研究结果.
主要方法:
- 发表的临床试验的文献综述.
- 对LD-RT影响的体外和体内研究的分析.
- 用LD-RT治疗的肺炎患者的临床和生物结果的检查.
主要成果:
- LD-RT显示出显著的抗炎性质.
- 研究表明,重症肺炎患者的临床和生物改善.
- 在重症肺炎病例中,LD-RT是一种可行的替代方案,尤其是在流行病期间.
结论:
- LD-RT是一种有前途的治疗方法,用于重症肺炎.
- 它的免疫调节和抗炎作用需要进一步研究.
- 当传统疗法有限时,LD-RT可能是关键的治疗选择.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
370
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
370
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
189
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
189
COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
Pneumothorax-II
127
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
127
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


